Unveiling the rise of Candida auris: Latest developments and healthcare implications

, a fungus that is resistant to multiple drugs, has become a major global healthcare concern in recent years. The pathogen quickly disseminates within healthcare facilities, colonizes many surfaces, and leads to recurrent infections despite frequent disinfection measures. Automated systems frequently misidentify it, resulting in a delayed diagnosis. Inadequate hand hygiene, the use of multiple antibiotics, and contaminated medical equipment are the main causes of infections that primarily target critically ill patients in hospital intensive care units (ICUs). isolates are resistant to commonly used antifungal drugs like fluconazole, amphotericin, and echinocandins. This review article thoroughly examines the current understanding of infections, encompassing its epidemiology, clinical symptoms, diagnosis, treatment options, and prevention measures. It additionally summarizes a recent literature review on emerging diagnostic techniques and treatment options. Gaining a comprehensive understanding of the difficulties presented by this pathogen and staying informed of the most recent developments is essential for healthcare providers and policymakers in order to efficiently counteract its transmission and limit its detrimental impact on patient health